Administrative Core Core facilities in the Department of Anatomy/Cell Biology and [Ophthalmology] are fully accessible to all Core grant participants and continue to be available on a [first-signed-up. first-served basis], with overall priority for NEI-R01 funded scientists (fully described in the cores). The facilities continue to enhance NEI-funded studies, and provide an atmosphere that actively encourages and enhances collaboration among NEI-funded investigators and their collaborators both at WSU and nearby Oakland University. The facilities also provide important assistance, but at lower priority [(project will take longer to complete, for example)], to non-NEI funded investigators to carry out pilot studies whose outcome hold relevancy for the mission of the NEI. (e.g., microRNA in retina studies of newly recruited. Dr. Shunbin Xu).The proposed facilities requested for continued support include the following cores: Imaging/Histopathology, [Immunology], and Tissue Culture/Molecular. Support also is requested for the PD/PI of the Administrative core, but no other costs are charged to the grant for this core. Those costs (secretarial and administrative assistant as well as supplies, computer access, printers, telephones, etc.) will be borne by the Anatomy/Cell Biology Department, as they have since the inception of this P30 award. The overall administration of this Core also has profited by the presence of an advisory group (Executive Committee) to the PI. This Committee also reviews requests for pilot support on an as needed basis and determines competitive vision projects that will be facilitated within the cores through financial support from the office of the Vice Dean for Research (see letter of support, Bonita Stanton, M.D.). [We expect to fund maximally 5 new projects, with $2,000.00 per project ($10,000/year/5 years) allotted to help offset costs]. The administration of the Core grant is the responsibility of the PD/PI, Dr. Hazlett who also will continue to direct the l/H core. Should her ROl funding status become an issue. Dr. Fu-Shin Yu. Director of Research. KEl. is fully ready and qualified to serve as director of the l/H core. In her role as PD/PI. Dr. Hazlett is assisted and advised by an Executive Committee: Dr. Ashok Kumar [(Director, Immunology core] and Dr. Z. Pan (Scientific Director ofthe Ligon Center, KEl and Director, Tc/Mol core). The committee meets quarterly to oversee the use of the cores, encourage and develop new areas of investigation and collaboration, competitively review pilot projects planned requesting financial support (See letter of support, Dr. Stanton), and resolve any issues regarding efficient operation of the cores. [Should this group not effectively resolve a dispute, in future, the PI will present the issue to the Office of Faculty Affairs School of Medicine (Dr. Sonnino) for impartial advice and consult toward a fair and equitable resolution. That said, we have not had any such issues in the entire life-time of this core].Two additional meetings also are held involving all Core vision scientists to review research progress and to determine satisfaction levels, as well as how the cores could change to improve on their services or add new ones, such as the new Immunology core, for example. One of the meetings occurs in early December and coincides with the time when the non-competitive continuation application for the Core grant is being prepared for submission to NEI. [Because of the smooth operation of the Core grant facilitating as top priority. NEI ROl funded studies, and also, at lesser priority, those studies currently not funded by NEI support, no yearly external review has been done to evaluate the ongoing activities of the group. Should this evaluation become necessary in future, due to a decrease in productivity, lack of collaboration, or other major issues, the following panel of individuals [(External Advisory Board) will be contacted to review our progress and provide advice: Ilene Gipson, PhD - Professor of Ophthalmology, Harvard and Ocular Surface Scholar and Senior Scientist Schepens, David Beebe, PhD, Professor, Ophthalmology and Visual Sciences, Washington University, St. Louis, MO. and Sally Atherton, Executive Director, ARVO (Support letters included). The Department of Anatomy/Cell Biology will provide travel funds/expenses and an honorarium to each of the above individuals. These measures ensure that the administrative aspects of the Core grant will continue to be carried out smoothly and effectively]. Secretarial, clerical and managerial support for Core grant administration are provided by the School of Medicine General Fund allocation to the Anatomy/Cell Biology Department. Duties include, (a) preparation of progress reports and other relevant correspondence, (b) assistance in the preparation of manuscripts related to the research activities of the Core group and (c) assistance in the maintenance of proper fiscal and other operational records. Selina Latimore-Hall, secretary and Terri Larrew, Administrative Assistant performed these duties in an exemplary manner and continue to be housed in the main office of Anatomy/Cell Biology. Terri Larrew will continue to be responsible for maintaining departmental (research and non-research) financial budget records, and for the coordination of general departmental activities. [She is fully familiar with and uses daily the University based systems for finance oversight and input. She prepares reports at least quarterly to the PD/PI (Dr. Hazlett) who in turn shares Core grant relevant information with the core directors. The systems used to perform these functions, include: Banner Finance which is part of WSU's Banner ERP system. The Finance unit of the university maintains the university's chart of accounts, posts financial transactions, and provides financial reporting. It is the

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Center Core Grants (P30)
Project #
2P30EY004068-31A1
Application #
8877738
Study Section
Special Emphasis Panel (ZEY1-VSN (03))
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
31
Fiscal Year
2014
Total Cost
$17,511
Indirect Cost
$6,022
Name
Wayne State University
Department
Type
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Yan, Chenxi; Gao, Nan; Sun, Haijing et al. (2016) Targeting Imbalance between IL-1β and IL-1 Receptor Antagonist Ameliorates Delayed Epithelium Wound Healing in Diabetic Mouse Corneas. Am J Pathol 186:1466-80
Thomas, Jennifer L; Ranski, Alexandra H; Morgan, Gregory W et al. (2016) Reactive gliosis in the adult zebrafish retina. Exp Eye Res 143:98-109
Lu, Q; Ganjawala, T H; Ivanova, E et al. (2016) AAV-mediated transduction and targeting of retinal bipolar cells with improved mGluR6 promoters in rodents and primates. Gene Ther 23:680-9
Farshi, Pershang; Fyk-Kolodziej, Bozena; Krolewski, David M et al. (2016) Dopamine D1 receptor expression is bipolar cell type-specific in the mouse retina. J Comp Neurol 524:2059-79
Gaddipati, Subhash; Rao, Pushpa; Jerome, Andrew David et al. (2016) Loss of Neurokinin-1 Receptor Alters Ocular Surface Homeostasis and Promotes an Early Development of Herpes Stromal Keratitis. J Immunol 197:4021-4033
Singh, P K; Kumar, A (2016) Mitochondria mediates caspase-dependent and independent retinal cell death in Staphylococcus aureus endophthalmitis. Cell Death Discov 2:16034
Muraleedharan, Chithra K; McClellan, Sharon A; Barrett, Ronald P et al. (2016) Inactivation of the miR-183/96/182 Cluster Decreases the Severity of Pseudomonas aeruginosa-Induced Keratitis. Invest Ophthalmol Vis Sci 57:1506-17
Shi, Haoshen; Carion, Thomas W; Jiang, Youde et al. (2016) VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1. Prostaglandins Other Lipid Mediat 123:28-32
Ye, Eun-Ah; Liu, Li; Jiang, Youde et al. (2016) miR-15a/16 reduces retinal leukostasis through decreased pro-inflammatory signaling. J Neuroinflammation 13:305
Liu, Li; Jiang, Youde; Steinle, Jena J (2016) Compound 49b Restores Retinal Thickness and Reduces Degenerate Capillaries in the Rat Retina following Ischemia/Reperfusion. PLoS One 11:e0159532

Showing the most recent 10 out of 311 publications